These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 8713111

  • 1. Ligand-induced dimerization of the extracellular domain of the TGF-beta receptor type II.
    Letourneur O, Goetschy JF, Horisberger M, Grütter MG.
    Biochem Biophys Res Commun; 1996 Jul 25; 224(3):709-16. PubMed ID: 8713111
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Fermentable metabolite of Zymomonas mobilis controls collagen reduction in photoaging skin by improving TGF-beta/Smad signaling suppression.
    Tanaka H, Yamaba H, Kosugi N, Mizutani H, Nakata S.
    Arch Dermatol Res; 2008 Apr 25; 300 Suppl 1():S57-64. PubMed ID: 18060420
    [Abstract] [Full Text] [Related]

  • 5. Rap1 reverses transcriptional repression of TGF-beta type II receptor by a mechanism involving AP-1 in the human pancreatic cancer cell line, UK Pan-1.
    Fralix KD, Zhao S, Venkatasubbarao K, Freeman JW.
    J Cell Physiol; 2003 Jan 25; 194(1):88-99. PubMed ID: 12447993
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Concurrent and distinct transcription and translation of transforming growth factor-beta type I and type II receptors in rodent embryogenesis.
    Mariano JM, Montuenga LM, Prentice MA, Cuttitta F, Jakowlew SB.
    Int J Dev Biol; 1998 Nov 25; 42(8):1125-36. PubMed ID: 9879710
    [Abstract] [Full Text] [Related]

  • 8. Alternative splicing of TGF-betas and their high-affinity receptors T beta RI, T beta RII and T beta RIII (betaglycan) reveal new variants in human prostatic cells.
    Konrad L, Scheiber JA, Völck-Badouin E, Keilani MM, Laible L, Brandt H, Schmidt A, Aumüller G, Hofmann R.
    BMC Genomics; 2007 Sep 11; 8():318. PubMed ID: 17845732
    [Abstract] [Full Text] [Related]

  • 9. Expression of recombinant human soluble type II transforming growth factor-beta receptor in Pichia pastoris and Escherichia coli: two powerful systems to express a potent inhibitor of transforming growth factor-beta.
    Glansbeek HL, van Beuningen HM, Vitters EL, van der Kraan PM, van den Berg WB.
    Protein Expr Purif; 1998 Mar 11; 12(2):201-7. PubMed ID: 9518461
    [Abstract] [Full Text] [Related]

  • 10. Transforming growth factor-beta regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment.
    Bierie B, Stover DG, Abel TW, Chytil A, Gorska AE, Aakre M, Forrester E, Yang L, Wagner KU, Moses HL.
    Cancer Res; 2008 Mar 15; 68(6):1809-19. PubMed ID: 18339861
    [Abstract] [Full Text] [Related]

  • 11. Signal transduction by transforming growth factor-beta: a cooperative paradigm with extensive negative regulation.
    Engel ME, Datta PK, Moses HL.
    J Cell Biochem Suppl; 1998 Mar 15; 30-31():111-22. PubMed ID: 9893262
    [Abstract] [Full Text] [Related]

  • 12. Mouse embryonic stem cells with aberrant transforming growth factor beta signalling exhibit impaired differentiation in vitro and in vivo.
    Goumans MJ, Ward-van Oostwaard D, Wianny F, Savatier P, Zwijsen A, Mummery C.
    Differentiation; 1998 Jul 15; 63(3):101-13. PubMed ID: 9697304
    [Abstract] [Full Text] [Related]

  • 13. Crystal structure of the human TbetaR2 ectodomain--TGF-beta3 complex.
    Hart PJ, Deep S, Taylor AB, Shu Z, Hinck CS, Hinck AP.
    Nat Struct Biol; 2002 Mar 15; 9(3):203-8. PubMed ID: 11850637
    [Abstract] [Full Text] [Related]

  • 14. Contextual effects of transforming growth factor beta on the tumorigenicity of human colon carcinoma cells.
    Ye SC, Foster JM, Li W, Liang J, Zborowska E, Venkateswarlu S, Gong J, Brattain MG, Willson JK.
    Cancer Res; 1999 Sep 15; 59(18):4725-31. PubMed ID: 10493532
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Growth inhibition due to complementation of transforming growth factor-beta receptor type II-defect by human chromosome 3 transfer in human colorectal carcinoma cells.
    Miyafuji Y, Zhong X, Uchida I, Koi M, Hemmi H.
    J Cell Physiol; 2001 Jun 15; 187(3):356-64. PubMed ID: 11319759
    [Abstract] [Full Text] [Related]

  • 17. Interaction of transforming growth factor beta receptors with apolipoprotein J/clusterin.
    Reddy KB, Karode MC, Harmony AK, Howe PH.
    Biochemistry; 1996 Jan 09; 35(1):309-14. PubMed ID: 8555189
    [Abstract] [Full Text] [Related]

  • 18. TGF-beta receptors: structure and function.
    Lin HY, Moustakas A.
    Cell Mol Biol (Noisy-le-grand); 1994 May 09; 40(3):337-49. PubMed ID: 7920178
    [Abstract] [Full Text] [Related]

  • 19. Transforming growth factor-beta receptors in human cancer cell lines: analysis of transcript, protein and proliferation.
    Jakowlew SB, Moody TW, Mariano JM.
    Anticancer Res; 1997 May 09; 17(3C):1849-60. PubMed ID: 9216635
    [Abstract] [Full Text] [Related]

  • 20. Cooperative binding of transforming growth factor (TGF)-beta 2 to the types I and II TGF-beta receptors.
    Rodriguez C, Chen F, Weinberg RA, Lodish HF.
    J Biol Chem; 1995 Jul 07; 270(27):15919-22. PubMed ID: 7608141
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.